June 4, 2021 Allergy/Immunology Pfizer vaccine recipients have lower neutralizing antibodies targeting delta variant up to three months after first dose. Outcome data needed to determine if this translates into less efficacy. Study concludes second dose interval needs to be shortened.
June 3, 2021 Allergy/Immunology Study concludes that there was no evidence to support vitamin D supplementation in the general population would improve COVID-19 outcomes.
May 27, 2021 Allergy/Immunology German study proposes a mechanism behind the rare blood clots associated with AstraZeneca vaccine.
May 6, 2021 Allergy/Immunology Jury still out on mixing and matching vaccines. Picture to become much clearer very soon with studies to come but assumption is that it should work given existing vaccines stimulate production of the spike protein with similar endpoint efficacy.
May 3, 2021 Allergy/Immunology The development of mRNA vaccine technology has the potential to expand to treat and prevent other diseases akin to the technological spinoffs seen with the Apollo space program.
April 9, 2021 Allergy/Immunology Will Covid vaccine mixing be adopted as health policy? They use different delivery systems carrying the genetic instruction set to produce the same spike protein, ergo ongoing studies are evaluating clinical outcomes to determine if assumption is true.
March 10, 2021 Allergy/Immunology New T-cell test to determine past exposure to SARS-CoV-2 is cool science but not a game changer. It may help answer why some become long-haulers after infection while others do not and it is a starting point for discovery and treatment research.
February 25, 2021 Allergy/Immunology Study proposes a biological mechanism to explain how high fructose exposure can exacerbate immune inflammatory response.
February 9, 2021 Allergy/Immunology Unpublished, uncontrolled small study claims that experimental exosome treatment shortens recovery time to five days for patients with severe Covid-19. Further human trials required to prove it truly works.
February 4, 2021 Allergy/Immunology Lancet posts Oxford Vaccine Group preprint study on how the timing of the booster dose of its Oxford-AZ vaccine affects the immune response and efficacy for people 18-55 years of age.